# A Study of Intrathecal SHP611 in Children With Metachromatic Leukodystrophy

> **NCT03771898** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Shire** · enrollment: 36 (actual)

## Conditions studied

- Metachromatic Leukodystrophy (MLD)

## Interventions

- **DRUG:** SHP611

## Key facts

- **NCT ID:** NCT03771898
- **Lead sponsor:** Shire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-05-13
- **Primary completion:** 2023-03-08
- **Final completion:** 2026-05-01
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2026-04-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03771898

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03771898, "A Study of Intrathecal SHP611 in Children With Metachromatic Leukodystrophy". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT03771898. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*